市場調查報告書
商品編碼
1557321
醫用合成橡膠市場:2024-2029 年預測Medical Elastomers Market - Forecasts from 2024 to 2029 |
全球醫用合成橡膠市場預計將從2024年的93.64億美元增加到2029年的138.25億美元,複合年成長率為8.10%。
合成橡膠是一種具有高物理性能、柔韌性、熱塑性和滅菌性能的材料。這些特性使它們適合醫療應用,例如血壓管、流體通道、傷口引流和藥物傳輸系統。
推動市場擴張的主要因素是在一次性醫療用品(例如管子、注射器和閥門)的製造中擴大使用合成橡膠。這些醫療設備需要多種物理特性,例如柔韌性以及耐高溫和耐化學藥品。此外,對人工關節和心臟瓣膜必不可少的植入的需求不斷增加,也促進了市場的成長。
此外,矽膠用於生物醫學產品的封裝,由於產品開發和市場開拓有無數的機會,預計全球需求將大幅成長。
合成橡膠廣泛用於製造心血管裝置、矯正器具、一般醫療產品、經皮治療系統、矯正等。如此廣泛的使用是由於生物相容性、耐用性、設計靈活性和良好的性能/成本比。這種成長可歸因於醫療產品中使用的安全無鹵聚合物的需求激增。
多年來,心血管病等重大慢性病的流行已成為重大健康問題。例如,根據世界衛生組織 (WHO) 的統計,心血管疾病是死亡的主要原因之一,估計每年導致 1,790 萬人死亡。同樣,根據美國心臟學會的一項研究,到2022年,全球因心血管疾病死亡的人數將達到1,980萬人。如此高的死亡率強調了用於心血管應用的人造心臟瓣膜和血管移植物的發展,從而增強了對合成橡膠的需求。
合成橡膠的靈活性使其成為創建可用作流體通道或人工瓣膜的可自訂管道的理想選擇。在醫療保健領域,由於流體輸送和藥物應用對醫用管材的需求不斷增加,以及肺癌、氣喘和肺纖維化等呼吸系統疾病的迅速增加,對材料的需求正在迅速增加。
此外,人口老化和慢性病數量的增加,對微創醫療程序和一次性管式醫療設備的需求不斷增加,也促進了醫療管市場的成長。此外,各種醫療設備公司之間的策略併購預計將推動全球一次性醫療設備的需求和滲透,從而推動市場成長。
全球醫用合成橡膠細分市場分析
依類型分類,全球醫用合成橡膠市場分為熱固性合成橡膠、矽膠、熱可塑性橡膠等。由於其高生物相容性、柔韌性以及機械和電阻,矽膠主要用於醫療應用,如醫用袋、手套、管材和植入。由於其高偏好,有機矽彈性合成橡膠佔據了重要的市場佔有率,並將在預測期內穩定成長。類似地,熱可塑性橡膠和熱固性合成橡膠也被認為表現出持續成長。
依應用分類,全球醫用合成橡膠市場分為植入、注射器、醫用袋、手套、醫用管材等。由於合成橡膠主要用於製造血流管、熱縮管、流體通道,並且主要用於快節奏的外科手術,因此醫療管預計將持續成長並佔據較大的市場佔有率。
持續投資和策略聯盟,以加強對微創手術中客製化醫療管的重視,正在推動該領域的整體成長。同樣,由於植入將穩定成長。
亞太地區在預測期內將經歷指數級成長
按地區分類,全球醫用合成橡膠市場分為北美、南美、歐洲、中東和非洲以及亞太地區。由於中國和日本等國家的人口老化以及慢性病的流行以及對醫療干預和治療的需求不斷增加,亞太地區的醫用合成橡膠市場顯示出巨大的潛力。
此外,不斷增加的研發投入、醫療設備的創新以及政府積極改善老年人慢性病治療的努力,都進一步為區域市場的擴張鋪平了道路。
同樣,隨著創傷、重組和義肢手術規模的擴大,以及合成橡膠成為重組植入的更好替代品並用作組織擴張器,預計北美將出現積極成長。根據美國整形外科醫師協會統計,2023年共有157,740例乳房重建手術,比2022年增加了4%。
The global medical elastomer market is expected to reach US$13.825 billion in 2029 from US$9.364 billion in 2024 at 8.10% (CAGR).
Elastomers are materials with high physical performance, flexibility, thermoplastics, and sterilization properties. These properties make them suitable for medical applications such as blood pressure tubing, fluid pathways, wound drainage, and drug delivery systems.
The prime factor propelling the market expansion is the growing use of elastomers in the manufacturing of disposable medical supplies like tubing, syringes, and valves, among other medical devices. These devices require diverse physical features like flexibility and resistance to high temperatures and chemicals. Furthermore, the increasing need for vital implants for prosthetic joints and heart valves has also contributed to market growth.
In addition, silicone is anticipated to experience a notable surge in demand globally as it is used to encapsulate biomedical products and presents countless opportunities for product development and market introduction.
Elastomers are extensively used in the manufacturing of cardiovascular devices, prosthetic devices, general medical care products, transdermal therapeutic systems, orthodontics, etc. This extensive use is due to their biocompatibility, durability, design flexibility, and favorable performance/cost ratios. The growth may be attributed to the surge in demand for safe and halogen-free polymers used in medical products.
Over the years, the prevalence rate of major chronic diseases such as cardiovascular has become a major health issue. For instance, according to the World Health Organization, cardiovascular disease has become one of the leading causes of death, accounting for an estimated 17.9 million annually. Likewise, as per the study conducted by the American College of Cardiology, in 2022, the global number of deaths due to cardiovascular disease reached 19.8 million. Such a high death count will emphasize the development of artificial heart valves and vascular prostheses for cardiovascular applications, thereby bolstering the demand for elastomers.
Elastomers, due to their higher flexibility, have become an ideal choice for making customizable tubes that can be used as fluid pathways and artificial valves. The demand for materials is booming in the healthcare sector owing to the increasing requirement for fluid delivery medical tubes and medication applications and the escalation of respiratory diseases, including lung cancer, asthma, and pulmonary fibrosis.
Moreover, the aging population and rising rates of chronic diseases, followed by the growing need for minimally invasive medical procedures and disposable tube-based medical equipment, all contribute to the medical tube market growth. Additionally, strategic mergers and acquisitions among different medical device companies are anticipated to propel the demand and reach of disposable medical devices globally, thereby propelling market growth.
Global Medical Elastomer Market Segment Analysis
Based on type, the global medical elastomer market is divided into thermoset elastomer, silicone, thermoplastic elastomer, and others. Silicon offers high bio-compatibility processing flexibility and mechanical & electrical resistance, owing to which it is majorly used in medical applications such as medical bags, gloves, tubes, and implants. Due to their high preference, silicon-based elastomers account for a considerable market share and will grow steadily during the forecast period. Likewise, the thermoplastic and thermoset elastomers are estimated to show constant growth.
Application-wise, the global medical elastomer market is analyzed into implants, syringes, medical bags, gloves, medical tubes, and others. Medical tubes are poised for constant growth and will hold a significant market share as the elastomers are mainly used for making blood flow tubing, heat shrink tubing, and fluid pathways, which are majorly used in fast-paced surgical procedures.
The growing emphasis on customized medical tubes in minimally invasive surgeries, followed by ongoing investments and strategic collaboration to bolster them, has bolstered the overall segment growth. Likewise, implants are also expected to grow at a steady rate, fuelled by their growing applicability in artificial heart valves.
Asia Pacific is witnessing exponential growth during the forecast period
Region-wise, the global medical elastomers market is divided into North America, South America, Europe, the Middle East and Africa, and Asia Pacific. The APAC region shows great potential for the medical elastomer market fuelled by the booming chronic disease prevalence which has increased the demand for medical interventions and treatments driven by the large aging populations in countries like China and Japan.
Moreover, the growing research and development investments, technological innovations in medical devices, and favorable government efforts to improve chronic disease treatment for the geriatric population have further paved the way for regional market expansion.
Likewise, North America is also poised for positive growth owing to the growing scale of traumatic, reconstruction, and prosthetic surgeries, where the elastomers form a better alternative for deploying reconstructive implants and also act as tissue expanders. According to the American Society of Plastic Surgeons, in 2023, breast reconstruction surgery witnessed a 4% growth over 2022, with the total number of procedures recorded at 157,740.
The same source also specified that pelvic floor reconstruction procedures experienced a 7% growth in the same year. Additionally, the well-established presence of major market players, namely DuPont, which is investing in establishing new medical elastomer manufacturing units in the country, is augmenting the market expansion. The European and South American regions are expected to grow at a positive rate, whereas the Middle East and Africa will account for a minimal market share during the forecast period.